These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18307280)

  • 1. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
    Lönnroth C; Andersson M; Arvidsson A; Nordgren S; Brevinge H; Lagerstedt K; Lundholm K
    Cancer Immun; 2008 Feb; 8():5. PubMed ID: 18307280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment.
    Lönnroth C; Andersson M; Nordgren S; Lundholm K
    Int J Oncol; 2012 Jul; 41(1):15-23. PubMed ID: 22552364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.
    Lönnroth C; Andersson M; Asting AG; Nordgren S; Lundholm K
    Int J Oncol; 2014 Dec; 45(6):2208-20. PubMed ID: 25340937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
    Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor and enzyme expression for prostanoid metabolism in colorectal cancer related to tumor tissue PGE2.
    Gustafsson A; Andersson M; Lagerstedt K; Lönnroth C; Nordgren S; Lundholm K
    Int J Oncol; 2010 Feb; 36(2):469-78. PubMed ID: 20043083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
    Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation.
    Auman JT; Church R; Lee SY; Watson MA; Fleshman JW; Mcleod HL
    Eur J Cancer; 2008 Aug; 44(12):1754-60. PubMed ID: 18653328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
    Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
    Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.
    Håkansson L; Adell G; Boeryd B; Sjögren F; Sjödahl R
    Br J Cancer; 1997; 75(3):374-80. PubMed ID: 9020482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
    Scheen AJ
    Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer.
    de Heer P; Sandel MH; Guertens G; de Boeck G; Koudijs MM; Nagelkerke JF; Junggeburt JM; de Bruijn EA; van de Velde CJ; Kuppen PJ
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):811-9. PubMed ID: 18247029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
    Fischer SM; Lo HH; Gordon GB; Seibert K; Kelloff G; Lubet RA; Conti CJ
    Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study.
    Sakamoto C; Kawai T; Nakamura S; Sugioka T; Tabira J
    Aliment Pharmacol Ther; 2013 Feb; 37(3):346-54. PubMed ID: 23216412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.